la Fougere

@uni-tuebingen.de

Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tubingen
Eberhard Karls Universitat Tubingen

308

Scopus Publications

17439

Scholar Citations

66

Scholar h-index

216

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0
    H Barthel, M Brendel, N Albert, H Boecker, C Bouter, J Brumberg, ...
    Nuklearmedizin-NuclearMedicine 65 (03), 223-235 , 2026
    2026
  • Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study
    M Patel, W Feng, NS Mckay, PR Millar, M Liu, C Yang, A Cetin, ...
    The Lancet Neurology 25 (6), 581-590 , 2026
    2026
    Citations: 1
  • A longitudinal whole-body CT dataset with manually annotated tumor lesions
    S Gatidis, F Peisen, A Wagner, POM Choudja, A Othman, A Sanner, ...
    Scientific Data , 2026
    2026
  • The inflammatory fingerprint reveals immune cell populations associated with disease activity in cardiac sarcoidosis
    T Harm, SE Autenrieth, K Mezger, AK Rohlfing, H Dittman, C la Fougère, ...
    Clinical Research in Cardiology, 1-14 , 2026
    2026
  • The autoPET3 Challenge--Automated Lesion Segmentation in Whole-Body PET/CT-Multitracer Multicenter Generalization
    J Dexl, K Jeblick, A Mittermeier, B Schachtner, AT Stüber, J Topalis, ...
    arXiv preprint arXiv:2605.05775 , 2026
    2026
  • Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies
    PM Linder, W Lan, E Calderón, I Rausch, C la Fougère, FP Schmidt
    EJNMMI Physics , 2026
    2026
  • Beyond image quality: Patient experience with long-axial field-of-view and standard PET/CT systems
    D Sauerbrunn, N Schäffeler, J Sekler, J Jacoby, K Nikolaou, C la Fougère, ...
    European Journal of Nuclear Medicine and Molecular Imaging, 1-15 , 2026
    2026
  • Characterization of metabolic tumor kinetics in head and neck squamous cell carcinoma using ultra-late [18F] FDG PET imaging
    E Calderón, P Pelz, J von Fraunberg, S Böke, M Weissinger, H Dittmann, ...
    Nuklearmedizin-NuclearMedicine 65 (02), P24 , 2026
    2026
  • Real-world experience with lutetium (177Lu) vipivotide tetraxetan (177Lu-PSMA-617) in metastatic castration resistant prostate cancer (mCRPC): Results from the first interim …
    K Herrmann, C la Fougère, T Winkens, A Buck, F Zengerling
    Nuklearmedizin-NuclearMedicine 65 (02), V77 , 2026
    2026
  • Prognostic value of [64Cu] GD2 PET beyond [18F] FDG PET in sarcoma patients
    N Trautwein, H Dittmann, S Kailayangiri, CKW Deinzer, G Reischl, P Lang, ...
    Nuklearmedizin-NuclearMedicine 65 (02), V8 , 2026
    2026
  • PET-basierte prognostische Faktoren für mCRPC Patienten mit viszeralen Metastasen unter [177Lu] Lu-PSMA RLT
    M Späth, H Dittmann, R Spallek, E Calderon, J Mück, A Brendlin, ...
    Nuklearmedizin-NuclearMedicine 65 (02), P65 , 2026
    2026
  • Einsatz Somatostatinrezeptor (SSTR)-gerichteter Radioligandentherapie (RLT) bei Patienten mit pankreatischen neuroendokrinen Tumoren (panNET) in Deutschland
    M Schmidt, N Trautwein, C la Fougère, B Kreppel, M Essler, C Däubler, ...
    Nuklearmedizin-NuclearMedicine 65 (02), V38 , 2026
    2026
  • Histologische ex vivo Validierung von [18F] SiTATE für SSTR-PET bei Meningeomen
    R Gerdes, J Schittenhelm, S Singer, B Bender, C la Fougère, N Trautwein
    Nuklearmedizin-NuclearMedicine 65 (02), P20 , 2026
    2026
  • Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer’s disease
    ILH Choo, H Park, BA Gordon, RJ Bateman, R Bateman, AJ Daniels, ...
    The Journal of Prevention of Alzheimer's Disease 13 (4), 100513 , 2026
    2026
  • The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic …
    FL Giesel, SA Koerber, B Hadaschik, S Kiefer, S Schwarzenboeck, ...
    European journal of nuclear medicine and molecular imaging 53 (5), 2994-3006 , 2026
    2026
  • AutoPET challenge on fully automated lesion segmentation in oncologic PET/CT imaging, part 2: domain generalization
    J Dexl, S Gatidis, M Früh, K Jeblick, A Mittermeier, AT Stüber, ...
    Journal of Nuclear Medicine 67 (3), 481-488 , 2026
    2026
    Citations: 5
  • Exploring extended [ 18 F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT
    M Weissinger, S Ursprung, J Jacoby, J Vogel, E Calderón, B Gückel, ...
    European Journal of Nuclear Medicine and Molecular Imaging, 1-12 , 2026
    2026
  • Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report
    RD Lewetag, K Kluthe, NF Trautwein, UM Lauer, C la Fougère, B Sipos, ...
    Current Oncology 33 (2), 105 , 2026
    2026
  • Advancing Automated Lesion Segmentation Toward Clinical Integration in Oncologic PET/CT
    POM Choudja, J Dexl, M Frueh, K Jeblick, A Mittermeier, AT Stueber, ...
    ONCOLOGY RESEARCH AND TREATMENT 49, 237-237 , 2026
    2026
  • PET-imaging derived prognostic factors for prostate cancer patients with visceral metastases receiving [177Lu] Lu-PSMA radiopharmaceutical therapy (RPT)
    MS Späth, H Dittmann, R Spallek, E Calderón, J Mück, A Brendlin, ...
    European Journal of Nuclear Medicine and Molecular Imaging, 1-8 , 2026
    2026

MOST CITED SCHOLAR PUBLICATIONS

  • Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
    NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ...
    Neuro-oncology 18 (9), 1199-1208 , 2016
    2016
    Citations: 877
  • Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
    BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ...
    The Lancet Neurology 17 (3), 241-250 , 2018
    2018
    Citations: 740
  • Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ 18 F]FDG: version …
    I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ...
    European journal of nuclear medicine and molecular imaging 46 (3), 540-557 , 2019
    2019
    Citations: 617
  • Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison
    C La Fougere, A Zwergal, A Rominger, S Förster, G Fesl, M Dieterich, ...
    Neuroimage 50 (4), 1589-1598 , 2010
    2010
    Citations: 532
  • Attention deficit hyperactivity disorder: binding of [ 99m Tc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
    S Dresel, J Krause, KH Krause, C LaFougere, K Brinkbäumer, HF Kung, ...
    European journal of nuclear medicine 27 (10), 1518-1524 , 2000
    2000
    Citations: 397
  • A whole-body FDG-PET/CT dataset with manually annotated tumor lesions
    S Gatidis, T Hepp, M Früh, C La Fougère, K Nikolaou, C Pfannenberg, ...
    Scientific Data 9 (1), 601 , 2022
    2022
    Citations: 395
  • Molecular imaging of gliomas with PET: opportunities and limitations
    C la Fougere, B Suchorska, P Bartenstein, FW Kreth, JC Tonn
    Neuro-oncology 13 (8), 806-819 , 2011
    2011
    Citations: 374
  • PET and SPECT in epilepsy: a critical review
    C La Fougère, A Rominger, S Förster, J Geisler, P Bartenstein
    Epilepsy & Behavior 15 (1), 50-55 , 2009
    2009
    Citations: 333
  • Comparison of 68 Ga-labelled PSMA-11 and 11 C-choline in the detection of prostate cancer metastases by PET/CT
    J Schwenck, H Rempp, G Reischl, S Kruck, A Stenzl, K Nikolaou, ...
    European journal of nuclear medicine and molecular imaging 44 (1), 92-101 , 2017
    2017
    Citations: 325
  • Advances in PET imaging of cancer
    J Schwenck, D Sonanini, JM Cotton, HG Rammensee, C la Fougère, ...
    Nature Reviews Cancer 23 (7), 474-490 , 2023
    2023
    Citations: 314
  • DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
    F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ...
    Neuro-oncology 21 (7), 901-910 , 2019
    2019
    Citations: 284
  • Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
    M Kunz, N Thon, S Eigenbrod, C Hartmann, R Egensperger, J Herms, ...
    Neuro-oncology 13 (3), 307 , 2011
    2011
    Citations: 284
  • [ 18 F]-fluoro-ethyl- l -tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma
    M Hutterer, M Nowosielski, D Putzer, NL Jansen, M Seiz, M Schocke, ...
    Neuro-oncology 15 (3), 341-351 , 2013
    2013
    Citations: 273
  • Two decades of SPECT/CT–the coming of age of a technology: an updated review of literature evidence
    O Israel, O Pellet, L Biassoni, D De Palma, E Estrada-Lobato, ...
    European journal of nuclear medicine and molecular imaging 46 (10), 1990-2012 , 2019
    2019
    Citations: 264
  • The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder
    KH Krause, SH Dresel, J Krause, C la Fougere, M Ackenheil
    Neuroscience & Biobehavioral Reviews 27 (7), 605-613 , 2003
    2003
    Citations: 262
  • Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases
    LA Hoffmann, S Jarius, HL Pellkofer, M Schueller, M Krumbholz, F Koenig, ...
    Journal of Neurology, Neurosurgery & Psychiatry 79 (7), 767-773 , 2008
    2008
    Citations: 231
  • Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
    U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ...
    The Lancet Oncology 21 (4), 581-592 , 2020
    2020
    Citations: 230
  • Imaging and diagnostic advances for intracranial meningiomas
    RY Huang, WL Bi, B Griffith, TJ Kaufmann, C la Fougère, NO Schmidt, ...
    Neuro-oncology 21 (Supplement_1), i44-i61 , 2019
    2019
    Citations: 227
  • MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
    NL Jansen, V Graute, L Armbruster, B Suchorska, J Lutz, S Eigenbrod, ...
    European journal of nuclear medicine and molecular imaging 39 (6), 1021-1029 , 2012
    2012
    Citations: 220
  • Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM
    B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ...
    Neurology 84 (7), 710-719 , 2015
    2015
    Citations: 210